- Home
- MYGN vs VEL Comparison
MYGN vs VEL Comparison
Compare MYGN & VEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYGN
- VEL
- Stock Information
- Founded
- MYGN 1991
- VEL 2004
- Country
- MYGN United States
- VEL United States
- Employees
- MYGN N/A
- VEL N/A
- Industry
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- VEL Finance: Consumer Services
- Sector
- MYGN Health Care
- VEL Finance
- Exchange
- MYGN Nasdaq
- VEL Nasdaq
- Market Cap
- MYGN 744.7M
- VEL 680.6M
- IPO Year
- MYGN 1995
- VEL 2020
- Fundamental
- Price
- MYGN $5.34
- VEL $18.04
- Analyst Decision
- MYGN Hold
- VEL Buy
- Analyst Count
- MYGN 15
- VEL 5
- Target Price
- MYGN $15.14
- VEL $21.20
- AVG Volume (30 Days)
- MYGN 1.3M
- VEL 127.1K
- Earning Date
- MYGN 08-05-2025
- VEL 07-31-2025
- Dividend Yield
- MYGN N/A
- VEL N/A
- EPS Growth
- MYGN N/A
- VEL 14.80
- EPS
- MYGN N/A
- VEL 1.94
- Revenue
- MYGN $831,300,000.00
- VEL $177,987,000.00
- Revenue This Year
- MYGN N/A
- VEL N/A
- Revenue Next Year
- MYGN $6.68
- VEL $32.82
- P/E Ratio
- MYGN N/A
- VEL $9.26
- Revenue Growth
- MYGN 7.38
- VEL 39.36
- 52 Week Low
- MYGN $3.81
- VEL $16.12
- 52 Week High
- MYGN $29.30
- VEL $20.98
- Technical
- Relative Strength Index (RSI)
- MYGN 50.85
- VEL 45.89
- Support Level
- MYGN $4.90
- VEL $18.18
- Resistance Level
- MYGN $5.83
- VEL $18.89
- Average True Range (ATR)
- MYGN 0.28
- VEL 0.40
- MACD
- MYGN 0.04
- VEL -0.12
- Stochastic Oscillator
- MYGN 54.21
- VEL 5.88
About MYGN Myriad Genetics Inc.
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.
About VEL Velocity Financial Inc.
Velocity Financial Inc is a United States-based real estate finance company. The company originates and manages investor loans secured by residential rental and small commercial properties. The company earns revenue in the form of interest income. It operates in New York, California, Florida, New Jersey, and other states.